Ritu Agarwal, MD
- ASSISTANT PROFESSOR | Medicine, Liver Diseases
Specialties:Liver Medicine, Gastroenterology
American Board of Internal Medicine
Residency, Internal Medicine, Mount Sinai School of Medicine
Fellowship, Gastroenterology, Mount Sinai Hospital
- A Phase 3, Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study toInvestigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 12 Weeks in Direct-Acting Antiviral-Experienced Subjects with Chronic HCV Infection
The purpose of this study is to evaluate the efficacy, safety, and tolerability of SOF/VEL/GS-9857 FDC in patients infected with HCV. This is a randomized, double-blind, placebo-controlled study. Patients will be screened to see if they have genotype 1 HCV. If so, they will be...